Abstract

BackgroundTelaprevir is used in the treatment of chronic hepatitis C (HCV).PurposeTo find out at what point adverse reactions (ADRs) appear from the start of telaprevir treatment in order to prevent...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Desensitization reaction of patients with antituberculosis drug adverse reactions
B.S Vicente
The Journal of Allergy and Clinical Immunology | VOL. 113
B.S VicenteB.S Vicente
01 Feb 2004
Target Therapeutic Ranges of Anti-MRSA Drugs, Linezolid, Tedizolid and Daptomycin, and the Necessity of TDM
Sho Tashiro ... Xiaoxi Liu
Biological and Pharmaceutical Bulletin | VOL. 45
Sho Tashiro, et. al.Sho Tashiro ... Xiaoxi Liu
01 Jul 2022
Adverse reactions to oxacillin in hospitalized children: a prospective study
Raquel Araújo De Santiago ... Mariana De Oliveira Brizeno De Souza
Revista Brasileira de Saúde Materno Infantil | VOL. 7
Raquel Araújo De Santiago, et. al.Raquel Araújo De Santiago ... Mariana De Oliveira Brizeno De Souza
01 Mar 2007
Visualization and analysis of adverse reactions of molecularly targeted anticancer agents using the self-organizing map (SOM)
Junko Kawakami ... Kaori Ohtsuki
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan | VOL. 134
Junko Kawakami, et. al.Junko Kawakami ... Kaori Ohtsuki
01 Oct 2014
View more papers

More From: European Journal of Hospital Pharmacy: Science and Practice

Paper Title
Journal
Date
Author
EAHP and GS1 publish report of UZ Leuven meeting on bedside scanning and medicines bar coding
Richard Price
European Journal of Hospital Pharmacy: Science and Practice | VOL. 21
Richard PriceRichard Price
19 May 2014
In peer review we trust—or do we?
Phil Wiffen
European Journal of Hospital Pharmacy: Science and Practice | VOL. 21
Phil WiffenPhil Wiffen
19 May 2014
European Parliament Committee approves €3 billion public-private partnership with industry on new medicine development
European Journal of Hospital Pharmacy: Science and Practice | VOL. 21
19 May 2014
Chapter 5: Appraising the evidence
Phil Wiffen ... Hao Lu
European Journal of Hospital Pharmacy: Science and Practice | VOL. 21
Phil Wiffen, et. al.Phil Wiffen ... Hao Lu
19 May 2014
View more papers